chrisvoncsefalvay/vaers-outcomes huggingface dataset:
RECEIVED INJECTION AT 11:30AM, I AM 22 WEEKS PREGNANT, EST DELIVERY DATE 04/02/2022, ABOUT 2:30PM, STARTED GETTING RASH ON CHEEKS , WAS HOT TO THE TOUCH, STARTED GETTING RASH DOWN LEFT SIDE OF NECK, DECIDED TO GO TO ER, GAVE ME BENADRYL, DIDNT GET WORSE SEEM TO GET BETTER, HAD NO ISSUES SINCE.
My hair began to fall out in September of 2021. I have no nutritional deficiencies and very little stress. I did, however find a site with people claiming the same  (hair falling out months after getting the Moderna vaccine)
Lt foot started swelling evening of 24MAY91; By 27MAY91 foot really swollen nurse sent to clinic; Cellulitis did not respond to ATB; Md now feels may be arthralgia;
EXPLOSIVE DIARRHEA; GAS; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (EXPLOSIVE DIARRHEA) and FLATULENCE (GAS) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (EXPLOSIVE DIARRHEA) and FLATULENCE (GAS). At the time of the report, DIARRHOEA (EXPLOSIVE DIARRHEA) and FLATULENCE (GAS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Acute nausea onset 4-5hrs after injection. From hours 5-12, experienced continuous vomiting and diarrhea (approx. 5 - 15 minutes between bouts). Between 12-36 hours after injection, symptoms subsided to moderate nausea and extreme fatigue/muscle soreness. Mild nausea and fatigue continued for another 24 hours, then subsided.
Extreme burning sensation on the surface of my skin located on the front left torso as well as the back left torso of my body.  No rash, no redness,  no blisters. Just extreme burning sensation. Nothing helps it.
Numbness, pain, throbbing and burning feeling in both feet started a day or two after I got my vaccine. This is still ongoing.  I am going back to my doctor this month to talk about it again.
Shot was given very high in upper arm, just below the shoulder joint.  Tech went through the neck of my shirt, not a rolled up sleeve.  The shot hurt a little but nothing unusual. Within about 5 hours, my entire arm began to go numb and feel quite heavy.  By the time 8 hours had lapsed, my arm was paralized to the point that I could not lift it without using my other arm and hand to do so.  The pain was sharp in the shoulder joint the migrated down the length of my arm into my hand.   This severity level continued for four days. What sleep I got was sitting up. On October 24, I notified Dr. via message board. She called but offered no suggestions for pain relief or any ideas about regaining movement. Nor did she have any suggestions about how long the condition might persist.  By October 30, I was able to sleep in bed again and movement is pretty much back to normal although pain in the area below the injection site remains.
I had a incident of atrial fib, which required me to be cardioverted to correct it. I went to my cardiologist.
Headache right after 2nd shot lasted 1 month and at that time, sixth nerve palsy began in left eye. Was present for about 3 months, now sequential sixth nerve palsy in right eye. Still have double and blurred vision.
Nausea, headache, ear pain, sore throat, blurred vision, decreased concentration throughout course of injections 5/18/07-6/15/07
This spontaneous report was received from a medical assistant and refers to an unknown number of patients of unspecified demographics. No information regarding the patients' medical histories, concomitant medication and drug reactions or allergies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot# M035487, expiration date: 23-FEB-2019 (dose and route of administration were not reported). It was reported that the vaccines were exposed to the temperature range from 9 Celsius degrees to 25 Celsius degrees for a time frame of 2 hours 14 minutes. The temperature excursion was recorded by a digital data logger and there were no previous temperature excursions. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information is not expected since there was no consent for further contact. Sender's Comments: US-009507513-1705USA009556: US-009507513-1706USA003430: US-009507513-1706USA003432: US-009507513-1706USA003433.
Chills; Fever; stomach hurt; back hurt; Nausea; feel like she is about to pass out; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 28Apr2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feel like she was about to pass out on Apr2021. On 28Apr2021 the patient developed chills, fever, stomach hurt, back hurt and nausea. The event outcome was reported as unknown.   No follow-up attempts are needed. No further information expected
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. The patient was vaccinated with his first, second and third dose of GARDASIL (lot number not provided) on 15-MAR-2012, 16-APR-2013 and 17-MAY-2013, respectively. No adverse effect reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
persistent headaches; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEADACHE (persistent headaches) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (persistent headaches). At the time of the report, HEADACHE (persistent headaches) outcome was unknown. Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  No treatment information was provided.
Patient initially complained of itching all over his body. He had a red blotchy rash all over his body. Throughout the red blotchy area, he had large hives. The rash and hives began at approximately 6 pm on Friday, August 5, but could have possible started several hours sooner, as the mother-in-law initially thought that he just had a sunburn from being outside. He complained of itching and did not sleep well on Friday night. By Saturday morning, hislips were swollen as well as his cheeks. He did not have any difficulty breathing. He was covered with calamine lotion to help with the itching, and was given Benadryl to help with the swelling. After taking Benadryl, the swelling of the face and itching went away. He felt comfortable throughout Saturday, only complaining when the itching began again. He was covered with calamine lotion when the itching got uncomfortable and was given Benadryl every five hours. On Sunday morning, he woke up with swollen eyelids and more swelling on the face. A dose of Benadryl helped. The swellings/itching has decreased in area and intensity since Saturday, but he still has some areas on August 9. I spoke with the nurse on Monday to inform them of the reaction. Between Wednesday and Friday, he was not exposed to any new plants, animals, soaps, or foods that he had not been previously exposed to. There was no indications of any insect bites on his body.
pt began elevated temp 530 on 5NOV98 according to mom temp cont to increase to 103.8;pt was fussy & wouldn't allow anyone to touch the leg where one of the vax was given;
Student presents to clinic on 12/07/2009 stating right deltoid muscle still remains sore from injection of vaccination.
Fever, Tremors/shaking, muscle twitching, muscle spasms. dizziness, numbness/tingling in legs, electrical like feeling throughout body date of reaction. Continue to have muscle twitching, spasms, dizziness at the current time.
Chills with shaking , the next morning my husband found me passed out on the tile floor,bruised ribs
This spontaneous report was received from a healthcare worker refers to a 54 year old female patient. No medical history was reported. The patient is allergic to erythromycin. On 28-JUL-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot# J002777, expiry: 07-JUN-2014), subcutaneously. Concomitant therapies included AMITIZA, lorazepam, lisinopril (manufacturer unknown) and SINGULAIR. On 28-JUL-2013, the patient developed an injection site reaction following vaccination with ZOSTAVAX. The injection site reaction was described as a large localized injection site reaction red accompanied by a low grade fever (no rash). Patient sought medical attention: contacted office. Patient received treatment with TYLENOL and antihistamine (unspecified). Laboratory diagnostics studies performed were none. The outcome of low grade fever and injection site red was reported as not recovered. Additional information has been requested.
nausea; chills; malaise; This is a spontaneous report from a contactable nurse reported for herself. A 49-year old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) via unspecified route of administration at left arm on 23Dec2020 15:30 at single dose for Covid-19 immunization in a hospital facility. Medical history included Sjogren's syndrome, and chronic sinusitis. The patient was not diagnosed with COVID-19 and did not receive other vaccine in four weeks prior to Covid vaccination. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL), colestyramine (questran), lifitegrast (XIIDRA), and chondroitin sulfate, glucosamine hydrochloride (OSTEO BI-FLEX); all from unspecified date for unspecified indication. The patient previously took codeine and Ceftin; both experienced allergies. On 26Dec2020 08:00 three days after receiving vaccine, the patient experienced nausea, chills and malaise. The symptoms lasted for four days (Dec2020). The patient has not been tested for Covid-19 since the vaccination. The patient received no treatment due to the events. The outcome of the events nausea, chills and malaise was recovered. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.  Follow-up activities are possible, information on the batch number has been requested.
ACUTE NON ST ELEVATION MI 1/5/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Body aches; Severe itchiness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) and VACCINATION SITE PRURITUS (Severe itchiness at the injection arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN (Body aches) and VACCINATION SITE PRURITUS (Severe itchiness at the injection arm). At the time of the report, PAIN (Body aches) and VACCINATION SITE PRURITUS (Severe itchiness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
This spontaneous report was received from a health care worker referring to a 13 year old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 28-SEP-2015, the patient was vaccinated with unspecified improperly stored doses of GARDASIL 9 (lot # L016428, expiration date 30-JUL-2017), (routes, doses and anatomical sites of vaccination were not provided). It was reported that the temperature of excursion were the following: 53.6 F for 392 hours, 58.5 F for 465 hours and 46.2 F for 15 hours, respectively. The outcome of excursion was not supported. Co-suspect therapies or concomitant medications were not provided No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Healthcare worker reported of vaccine side effect which started  on 4/8/2021 @ 0700pm  CHILLS, WEAKNESS, TIREDNESS, BODYACHES, DIZZINESSS
It has been 2 weeks and the area where I received the shot is still painful, red, hard and hot to the touch.
pt recv vax 5JAN94 & several hr following vax pt devel reddened rash from lt upper arm to lt upper chest; inj site was more reddened than other areas & pt exp itching;
I contracted Covid19 on 5/10/2022 with symptoms of congestion, cough, fatigue, chills, loss of tasted on 5/15/2022. I am receiving monoclonal antibodies today 5/18/2022. My symptoms are improving but I am high risk/immunocompromised so my PCP is worried I may rebound.
Information has been received from an RN concerning a 64 year old white, obese female who on 11/14/01, at 11:00 AM, was vaccinated IM in the left deltoid with a dose of pneumococcal vaccine 23 polyvalent (lot 637263/1448K). Within the 1st 24 to 36 hours, she developed a fever. She also awoke in the middle of the night with swelling and redness at the injection site and the skin was hot to the touch and tender. It was approx. the size of a 50 cents piece. It was reported that the pt's temperature went to 101F. She had no other generalized or systemic symptoms. (Also reported achy feeling with her fever). The pt was seen in the doctor's office on 11/15/01 and was given diphenhydramine hydrochloride (Benadryl) (50mg q 6) and acetaminophen + propoxyphene napsylate (Darvocet 100 prn). She was also instructed to use cold compresses. Despite these actions, she had a worsening of the redness in her left upper arm and worsened tenderness. She was hospitalized on 11/16/01 because the physician was concerned she either had an allergic reaction to the vaccine, an early cellulitis or a necrotizing infection. Upon admission, her physical exam was normal except a fever of 100.5F and a soft ball size area of redness, tenderness and some heat on the left upper extremity. It was noted that while hospitalized she would be cultured and would continue on the Benadryl, Darvocet and cold compresses. She would also be started on IV antibiotics including vancomycin, gatifloxacin (Tequin) and metronidazole (Flagyl). It was reported upon discharge on 11/19/01 that the pt defervesed promptly from her admission fever. Her electrolytes were unremarkable. Her blood culture showed no growth. The pt was stable and afebrile with a marked decrease in the size of inflammation without evidence of fluctuates. Her blood pressure was elevated due to anxiety. She was discharged on Tequin 400mg 1 po daily for 10 days. It was noted that the pt had recovered.
pentacel was not mixed before administration with no reported adverse event; patient was administered with just the liquid portion of the Pentacel without the Hib component with no reported adverse event; Initial information received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 month old male patient who was administered with just the liquid portion of the diphtheria/tetanus/5 Hybrid AC Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] without the hib component with no reported adverse event and was not mixed before administration.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Pneumococcal Vaccine Conj 13v (Crm197) (Prevnar 13), Rotavirus Vaccine Live Reassort Oral 5v (Rotateq) And Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Hib Vaccine Conj (Menigococcal Protein), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid (Vaxelis) for Prophylactic vaccination.  On 19-Jul-2023, the patient received a Dose 2 at a dose of 0.5 ml of suspect /tetanus/5 Hybrid AC Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Suspension for injection (expiry date: 19-Oct-2023; lot UJ785AA) via intramuscular route in the right thigh for immunization and administered with just the liquid portion of the pentacel without the hib component with no reported adverse event (single component of a two-component product administered) (latency: same day).  On an unknown date the pentacel was not mixed before administration with no reported adverse event (product preparation error) (latency: same day).  It was reported "she called in together with the doctor to report that they have a patient who was administered with just the liquid portion of the PENTACEL; they have the patient back today to administer the Hib component and they ask which diluent is appropriate to prepare the dose; provided information to the practice manager and the doctor."  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Stroke; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2022US067671_OS (Novartis Pharmaceuticals Corporation).  A 75-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed. Unknown manufacturer.), for COVID-19 immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "Stroke". Clinical course was reported as, Patient stated that he had the COVID-19 booster vaccine and had a stroke.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt experienced acne on his back. This happens each time he get the Anthrax vaccine.
21 year old female complains of headache, congestion, and abdominal cramping after receiving the first COVID-19 vaccine.
3 hours after extreme nausea. 10 hours after shaking chills(rigors) lasting in waves for 6 hours then intermittently for 5 hours. Low grade Temp 100.3 Degrees , when I could take it.  Inconvenience of urine during the rigors. ?Migraine like? headache on right side involving my teeth for 12 hours and slowly abated after 24 hours. Unable to eat or drink for 42 hours with exception of  one cup green tea and 1/2 slice of provolone cheese., forced down only to take my Pradaxa. After rigors, whole body sweats for 8 hours.  As of today, I have had plain oatmeal and tea.
Patient states she received first COVID vaccination approximately one week ago (not a great historian); she tells me about 4 days later she became shorth of breath that progressively worsened - especially with exertion.  She went to ER and was sent home on steroids and antibiotics.  Shortness of breath became worsened so she presented back to ER and CTA was performed.  There is no evidence of PE but patient has what looks to be a chronic DVT of left subclavian vein extending up to IJ junction.  I do not believe this is for sure vaccine related but felt it was important to report it anyway.  She cannot tell me why she takes warfarin at home but I do assume it is for this known chronic DVT.  Unsure of Vaccine brand name.  Most vaccines in this area have been Moderna.
Syncope episode after given vaccine passed out for about 5 seconds EMTs checked her over & felt she was ok not to go to hospital, she did not want to go to the hospital.
Parkinson's Disease; mild dementia; Encephalopathy; This case was reported by a lawyer and described the occurrence of parkinson's disease in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number unk, expiry date unknown) for prophylaxis.   The patient's past medical history included parkinson's disease.   On 7th January 2020, the patient received Shingrix (intramuscular) 50 mcg. On 23rd January 2020, more than 2 weeks after receiving Shingrix, the patient experienced encephalopathy (serious criteria GSK medically significant). On an unknown date, the patient experienced parkinson's disease (serious criteria death and GSK medically significant) and dementia (serious criteria GSK medically significant). On an unknown date, the outcome of the parkinson's disease was fatal and the outcome of the encephalopathy and dementia were unknown. The patient died on 18th March 2020. The reported cause of death was parkinson's disease. An autopsy was not performed.   It was unknown if the reporter considered the parkinson's disease, encephalopathy and dementia to be related to Shingrix.  The initial information was received on 31 March 2021 via medical record (case is medically confirmed). As per pharmacy record, the patient ingested Shingrix 50mcg injection administered 0.5 ml in the muscles as directed on 07 January 2020. As per death certificate, patient died on 18 March 2020, the cause of death was Parkinson's Disease. The autopsy was not performed. The manner of death was natural. The patient had parkinsonism by September 2015. Patient has had evidence of parkinsonism and mild dementia. The patient experienced Encephalopathy diagnosed on 23 January 2020. He was hospitalized a day after shingles vaccine at which point he was noted to be encephalopathic. He remains encephalopathic although better than when in hospital.; Reported Cause(s) of Death: Parkinson's Disease
Six days (evening of 5/20) after the first dose of the COVID vaccine (Pfizer), Patient started to experience severe dizziness and nausea. Since that evening he has experienced the following: - Significant increase in heart rate when transitioning from laying down to sitting and/or standing.  - Severe dizziness - Excessive fatigue - Headaches - Gastrointestinal issues (constant nausea. Nausea increases in severity when standing. Diarrhea.)  - Muscle pain in his upper arms and upper legs  The above symptoms have continued 24/7 since their onset.
At the site of the vaccination, I have a rash that is approximately 3 1/2 - 4 inches in diameter,  I have 2 more areas of rash further down my arm above the elbow.